Amal Khouri
Director/Board Member en ANTIBE THERAPEUTICS INC. .
Fortuna: 628 608 $ al 31/03/2024
Perfil
Amal Khouri is an Independent Director at Antibe Therapeutics, Inc. and a Director at the Centre For Commercialization of Cancer Immunotherapy.
They previously served as the Chief Business Officer at Knight Therapeutics, Inc. and as the Head of Business Development at Paladin Labs, Inc. Amal also held a position as the Head of Partnering at Novartis Pharma AG.
They obtained an undergraduate degree from McGill University in 1997 and an MBA from the University of Ottawa in 2001.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 12/04/2024 | 152 212 ( 0.15% ) | 596 671 $ | 31/03/2024 | |
| 11/01/2024 | 95 334 ( 0.18% ) | 31 937 $ | 31/03/2024 |
Cargos activos de Amal Khouri
| Empresas | Cargo | Inicio |
|---|---|---|
| KNIGHT THERAPEUTICS INC. | Corporate Officer/Principal | 01/08/2014 |
| ANTIBE THERAPEUTICS INC. | Director/Board Member | 19/03/2018 |
Centre For Commercialization of Cancer Immunotherapy
 Centre For Commercialization of Cancer Immunotherapy Centre For Commercialization of Cancer Immunotherapy provides solution for the development, translation, and commercialization of cancer immunotherapy and regenerative medicine. It offers clinical research unit, contract research organization, and innovation and commercialization unit services. The company was founded by Lambert Busque, Denis-Claude Roy and is headquartered in Montréal, Canada. | Director/Board Member | - |
Antiguos cargos conocidos de Amal Khouri.
| Empresas | Cargo | Fin |
|---|---|---|
| PALADIN LABS INC. | Corporate Officer/Principal | 01/01/2014 |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
Formación de Amal Khouri.
| McGill University | Undergraduate Degree |
| University of Ottawa | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| KNIGHT THERAPEUTICS INC. | Health Technology |
| ANTIBE THERAPEUTICS INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Paladin Labs, Inc.
 Paladin Labs, Inc. Pharmaceuticals: MajorHealth Technology Paladin Labs Inc. operates as pharmaceutical company. It engages in developing, acquiring, in-licensing, marketing, and distributing innovative pharmaceutical products in Canada and internationally. The firm's products include Abstral, GlucaGen, Metadol, Plan B, Pennsaid, Seasonale, Testim, Twinject, Dexedrin, Tridural, and Trelstar. The company was founded by Jonathan Ross Goodman and Mark Beaudet on February 25, 1983 and is headquartered in Montreal, Canada. | Health Technology |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
Centre For Commercialization of Cancer Immunotherapy
Centre For Commercialization of Cancer Immunotherapy Centre For Commercialization of Cancer Immunotherapy provides solution for the development, translation, and commercialization of cancer immunotherapy and regenerative medicine. It offers clinical research unit, contract research organization, and innovation and commercialization unit services. The company was founded by Lambert Busque, Denis-Claude Roy and is headquartered in Montréal, Canada. |
- Bolsa de valores
- Insiders
- Amal Khouri
